BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Boehringer Ingelheim
Chinese Patent Office
Harvard Business School

Generated: January 22, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Israel Patent: 92952

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
TevaAZILECTrasagiline mesylateTABLET;ORAL021641-001May 16, 2006ABRXYesNo➤ Subscribe➤ SubscribeTREATMENT OF PARKINSON'S DISEASE
TevaAZILECTrasagiline mesylateTABLET;ORAL021641-002May 16, 2006ABRXYesYes➤ Subscribe➤ SubscribeTREATMENT OF PARKINSON'S DISEASE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist